Avaxia Biologics
Lexington
About Avaxia Biologics
Avaxia Biologics is a private, early-stage company developing orally-delivered antibody therapeutics using a proprietary antibody platform. The company is pursuing products for oral mucositis, inflammatory bowel disease, and diabetes, and obesity. Avaxia Biologics was founded in 2005 and headquartered in Lexington, Massachusetts.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $35.3M
- Funding stage: Early Stage Venture
- Last round: Convertible Note (Dec 2014)
- Website: avaxiabiologics.com
- Phone: (781) 861-0062
Industries & Categories
Biotechnology, Medical Device, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/avaxia-biologics-2232511 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.